Martin Skhreli

Showing 2 posts of 2 posts found.

mallinckrodt-project

Company in 85,000% infant epilepsy drug price increase receives $100 million fine

January 23, 2017
Sales and Marketing Mallinckrodt, Martin Skhreli

Mallinckrodt Pharmaceuticals has hit the headlines for particularly dispiriting reasons – with further evidence of practise by some companies that …

imprimis_logo

Imprimis launches low-cost Daraprim alternative

October 26, 2015
Sales and Marketing Daraprim, Imprimis, Martin Skhreli, turing

Imprimis Pharmaceuticals has announced that it has made available a customisable compounded formulation of pyrimethamine and leucovorin accessible for physicians …

The Gateway to Local Adoption Series

Latest content